VIEW ALL GALLERY BESIDES PICTURE UNDERMANTION

Monday 25 October 2010

Mesothelioma drug raltitrexed proves promising

Raltitrexed is being hailed as a beneficial drug when administered in combination with cisplatin for the treatment of mesothelioma. Created by AstraZeneca, raltitrexed is an antimetabolite, a chemical that stops the growth and division of cells. Fast cell growth and division characterizes many cancers, including malignant mesothelioma.
Mesothelioma is an aggressive cancer of the lung lining caused by asbestos fibers. Although it is a comparatively rare cancer, thousands of Americans suffer from

mesothelioma information

No comments:

Post a Comment